Dr. Shelley Sanford, PSY.D. Psychologist - Clinical Medicare: Not Enrolled in Medicare Practice Location: 2420 Linwood Dr # 3, Paragould, AR 72450 Phone: 870-236-9756 |
Philip Andrew Hestand, PH.D. Psychologist - Counseling Medicare: Not Enrolled in Medicare Practice Location: 1404 S 14th St, Paragould, AR 72450 Phone: 870-565-5295 |
Dr. Ashlie Williams, PSYD. Psychologist - Clinical Medicare: Accepting Medicare Assignments Practice Location: 1101 Morgan St, Suite 8, Paragould, AR 72450 Phone: 870-335-9483 Fax: 870-335-9487 |
Mr. Daniel Elliot Wysocki, LPE-I Psychologist Medicare: Not Enrolled in Medicare Practice Location: 1101 W Morgan St Ste 8, Paragould, AR 72450 Phone: 870-335-9483 Fax: 870-933-9487 |
News Archive
A study done in part by the University of Alberta shows that children treated with complementary and alternative medicine (CAM) have lower vaccination rates than the general population, exposing them to added risk from preventable illnesses such as mumps and measles.
GOP lawmakers hope to get back on the offensive in the Medicare debate. Ads will begin airing later this week that target a Democrat from Northern California, but some say the party needs to focus on a long-term strategy to regain its footing in this debate. Meanwhile, some House Democrats are pointing to a special congressional election in New York as proof that House Republican's Medicare vote is backfiring.
Washington State University researchers have found an unlikely recipe for antibiotic resistant bacteria: Mix cow dung and soil, and add urine infused with metabolized antibiotic. The urine will kill off normal E. coli in the dung-soil mixture. But antibiotic-resistant E. coli will survive in the soil to recolonize in a cow's gut through pasture, forage or bedding.
Capricor, Inc., a privately held biotechnology company focused on regenerative medicine, today announced that the U.S. Food and Drug Administration has approved initiation of its Investigational New Drug (IND) application for the ALLSTAR study, which will use allogeneic cardiac-derived stem cells (CDCs) to treat patients following large myocardial infarctions (MI).
Uroplasty, Inc. (NASDAQ: UPI) a medical device company that develops, manufactures and markets innovative proprietary products for the treatment of voiding dysfunctions, today announced that it will participate in the 9th Annual JMP Securities Healthcare Conference on Tuesday, June 24.
› Verified 1 days ago